2009
DOI: 10.2174/187152909789007025
|View full text |Cite
|
Sign up to set email alerts
|

Recent Advances in Biological Strategies for Targeted Drug Delivery

Abstract: Targeted drug delivery system, consisting of a guidance component, a transport vehicle and the drug, is aiming at distributing the drugs to a specific organ or cell type in a sufficient concentration to achieve the high efficiency and alleviate the side-effects of the drugs. During the past decade, besides physical and chemical methods, biological strategies have been developing at an amazing speed improving the drug targeting system. These include: i) searching for guidance components, which include integrin … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(15 citation statements)
references
References 184 publications
(192 reference statements)
0
15
0
Order By: Relevance
“…This approach, known as "targeted drug delivery", offers major advantages as compared with systemic drug distribution, ie, reduced toxicity owing to selective drug accumulation in the target area and increased therapeutic efficacy of the drug. 6 There are two basic principles suggested for targeted drug delivery into affected tissue using nanosized carriers. The first is usually referred to as "passive targeting", suggesting that the drug-loaded nanocarrier is passively retained in areas with increased microvascular permeability.…”
Section: Introductionmentioning
confidence: 99%
“…This approach, known as "targeted drug delivery", offers major advantages as compared with systemic drug distribution, ie, reduced toxicity owing to selective drug accumulation in the target area and increased therapeutic efficacy of the drug. 6 There are two basic principles suggested for targeted drug delivery into affected tissue using nanosized carriers. The first is usually referred to as "passive targeting", suggesting that the drug-loaded nanocarrier is passively retained in areas with increased microvascular permeability.…”
Section: Introductionmentioning
confidence: 99%
“…31 Detailed discussions of ligand-mediated nanoparticle targeting can be found in several reviews. 32 Peptides have also been identifi ed to enhance tumor penetration. Specifi cally, peptides with the motif R/KXXR/K bind to neuropilin-1, a co-receptor for vascular endothelial growth factor, and lead to enhanced cellular entry.…”
Section: Targeting Of Nanoparticlesmentioning
confidence: 99%
“…It has been shown for several tumor typologies that it is possible to either inhibit or interfere (both in vitro and in vivo) with the function of these molecules. This inhibition can be performed at both the gene transcription level using, for example, specific siRNA, and at the protein level using specific antibodies against ECM proteins (Sanz and Alvarez-Vallina, 2005;Aharinejad et al, 2007;Hsu et al, 2007;Kong and Mooney, 2007;Reardon et al, 2007;Ye and Yang, 2009;Weidle et al, 2011).…”
Section: Ecm Proteins As Molecular Targets In Melanoma Therapymentioning
confidence: 99%